epitope editing enables the use of novel immunotherapies for aml
Published 4 months ago • 36 plays • Length 2:29Download video MP4
Download video MP3
Similar videos
-
3:12
an epitope editing approach to enable the use of targeted immunotherapy in aml
-
2:33
novel immunotherapies in aml and insights into the future of the treatment landscape
-
1:29
the current landscape of immunotherapy for aml: an update from ash 2023
-
3:19
an overview of novel treatment approaches in tp53-mutated aml
-
2:16
the challenges in producing efficacious i-o products for aml
-
20:56
epitope prediction tools
-
7:30
canon medical anz product & technology update 2021 - ct and hit
-
1:46:07
hematology lecture
-
2:07
phase i/ii study of edit-301, a novel gene-edited autologous hsc medicine, in patients with scd
-
0:53
go-flag: bridge therapy to allo-sct in r/r aml
-
1:02
the impact of sequencing in aml
-
1:17
using an ai model to quantify under-utilization of allosct for aml in the uk
-
2:00
update of a phase i trial investigating lintuzumab-ac225 plus venetoclax in r/r aml
-
2:17
insights into the real-world efficacy of luspatercept in patients with lr-mds
-
3:10
novel aml treament approaches
-
1:02
maintenance therapy following treatment for amyloidosis
-
1:02
the use of car-t cell products in a real-world setting
-
3:13
targeting cd38 with a bispecific antibody to treat r/r aml: a phase i trial
-
5:31
cellular immunotherapy highlights from ebmt 2023
-
1:26
emerging management options for aml
-
5:11
an overview of the aims & work of the adwp